{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:00:39Z","timestamp":1792512039649,"version":"4.5.0"},"reference-count":124,"publisher":"European Respiratory Society (ERS)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2012,11,7]]},"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:p>Long-term macrolide treatment was first shown to alter the natural history of diffuse panbronchiolitis (DPB) in the late 1980s. Since then, macrolides have been demonstrated to exert anti-inflammatory and immunomodulatory activity in addition to being antimicrobial. Indeed, their spectrum of action extends to the regulation of leukocyte function and production of inflammatory mediators, control of mucus hypersecretion, resolution of inflammation and modulation of host defence mechanisms. As such, the potential benefit of macrolide antibiotics has been evaluated in a variety of chronic respiratory diseases. The best studied condition is cystic fibrosis, of which there have been six randomised controlled trials showing evidence of benefit. However, most of the studies were limited by small numbers of patients and short follow-up. More recently, landmark studies have demonstrated the efficacy of azithromycin in reducing the risk of acute exacerbations in patients with chronic obstructive pulmonary disease, but the optimal duration and dosing of macrolide treatment remain uncertain.<\/jats:p><jats:p>With the exception of patients with DPB and cystic fibrosis, until clear evidence of efficacy is available, the long-term use of macrolides should be limited to highly selected patients after careful evaluation of benefit and harm, or in the context of randomised controlled clinical trials.<\/jats:p>","DOI":"10.1183\/09031936.00136712","type":"journal-article","created":{"date-parts":[[2012,11,23]],"date-time":"2012-11-23T06:56:07Z","timestamp":1353653767000},"page":"239-251","source":"Crossref","is-referenced-by-count":121,"title":["Long-term macrolide treatment for chronic respiratory disease"],"prefix":"10.1183","volume":"42","author":[{"given":"Paolo","family":"Spagnolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo M.","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2012,11,22]]},"reference":[{"key":"2024102021263076000_42.1.239.1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/31.suppl_C.1"},{"key":"2024102021263076000_42.1.239.2","first-page":"480","article-title":"Penetration of macrolides into pulmonary sites of infection","volume":"16","author":"Bearden","year":"1999","journal-title":"Infect Med"},{"key":"2024102021263076000_42.1.239.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199708143370701"},{"key":"2024102021263076000_42.1.239.4","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.6.9710075"},{"issue":"Suppl. 9A","key":"2024102021263076000_42.1.239.5","first-page":"2","article-title":"Immunomodulatory properties of macrolides: overview and historical perspective","volume":"117","author":"Rubin","year":"2004","journal-title":"Am J Med"},{"key":"2024102021263076000_42.1.239.6","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/AAC.39.8.1688","article-title":"Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections","volume":"39","author":"Tamaoki","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"2024102021263076000_42.1.239.7","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.1.9612065"},{"key":"2024102021263076000_42.1.239.8","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.5.1581-1585.2004"},{"key":"2024102021263076000_42.1.239.9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000196450","article-title":"Effect of roxithromycin on peripheral neutrophil adhesion molecules in patients with chronic lower respiratory tract disease","volume":"62","author":"Kusano","year":"1995","journal-title":"Respiration"},{"key":"2024102021263076000_42.1.239.10","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00042208"},{"key":"2024102021263076000_42.1.239.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2006.00845.x"},{"key":"2024102021263076000_42.1.239.12","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00131805"},{"key":"2024102021263076000_42.1.239.13","doi-asserted-by":"publisher","DOI":"10.1378\/chest.98.4.917"},{"key":"2024102021263076000_42.1.239.14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000196514","article-title":"Interleukin 1\u03b2, tumour necrosis factor \u03b1, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy","volume":"63","author":"Sakito","year":"1996","journal-title":"Respiration"},{"key":"2024102021263076000_42.1.239.15","doi-asserted-by":"publisher","DOI":"10.1136\/thx.50.12.1246"},{"key":"2024102021263076000_42.1.239.16","doi-asserted-by":"publisher","DOI":"10.1159\/000195915"},{"key":"2024102021263076000_42.1.239.17","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.99.13613809"},{"key":"2024102021263076000_42.1.239.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(03)00042-8"},{"key":"2024102021263076000_42.1.239.19","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.50.4727"},{"key":"2024102021263076000_42.1.239.20","doi-asserted-by":"publisher","DOI":"10.1136\/thx.52.10.915"},{"key":"2024102021263076000_42.1.239.21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1148\/radiology.189.2.8210390","article-title":"Diffuse panbronchiolitis: follow-up CT examination","volume":"189","author":"Akira","year":"1993","journal-title":"Radiology"},{"key":"2024102021263076000_42.1.239.22","first-page":"CD007716","article-title":"Macrolides for diffuse panbronchiolitis","volume":"12","author":"Yang","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102021263076000_42.1.239.23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39391.713229.AD"},{"key":"2024102021263076000_42.1.239.24","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200304-505SO"},{"key":"2024102021263076000_42.1.239.25","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201009-1478CI"},{"key":"2024102021263076000_42.1.239.26","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-0132"},{"key":"2024102021263076000_42.1.239.27","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201009-1392OC"},{"key":"2024102021263076000_42.1.239.28","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201002-0203OC"},{"key":"2024102021263076000_42.1.239.29","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldn050"},{"key":"2024102021263076000_42.1.239.30","first-page":"1075","article-title":"Early pulmonary inflammation in infants with cystic fibrosis","volume":"151","author":"Khan","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102021263076000_42.1.239.31","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.3.212"},{"key":"2024102021263076000_42.1.239.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11081-6"},{"key":"2024102021263076000_42.1.239.33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.13.1749"},{"key":"2024102021263076000_42.1.239.34","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.057950"},{"key":"2024102021263076000_42.1.239.35","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00163306"},{"key":"2024102021263076000_42.1.239.36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.563"},{"key":"2024102021263076000_42.1.239.37","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21601"},{"key":"2024102021263076000_42.1.239.38","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1378\/chest.12-0628","article-title":"Effect of azithromycin on systemic markers of inflammation in cystic fibrosis patients uninfected with Pseudomonas aeruginosa","volume":"142","author":"Ratjen","year":"2012","journal-title":"Chest"},{"key":"2024102021263076000_42.1.239.39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/COPD.S681","article-title":"Role of macrolide therapy in chronic obstructive pulmonary disease","volume":"3","author":"Martinez","year":"2008","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024102021263076000_42.1.239.40","first-page":"CD002203","article-title":"Macrolide antibiotics for cystic fibrosis","volume":"11","author":"Southern","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102021263076000_42.1.239.41","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21613"},{"key":"2024102021263076000_42.1.239.42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra012519"},{"key":"2024102021263076000_42.1.239.43","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/thx.53.8.685","article-title":"Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis","volume":"53","author":"Gaga","year":"1998","journal-title":"Thorax"},{"key":"2024102021263076000_42.1.239.44","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10050994"},{"key":"2024102021263076000_42.1.239.45","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.99.13236199"},{"key":"2024102021263076000_42.1.239.46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2006.00708.x"},{"key":"2024102021263076000_42.1.239.47","first-page":"540","article-title":"Prophylactic antibiotic treatment of bronchiectasis with azithromycin","volume":"59","author":"Davies","year":"2004","journal-title":"Thorax"},{"key":"2024102021263076000_42.1.239.48","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60953-2"},{"key":"2024102021263076000_42.1.239.49","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00103307"},{"key":"2024102021263076000_42.1.239.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.10.048"},{"key":"2024102021263076000_42.1.239.51","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2011.32.3431"},{"key":"2024102021263076000_42.1.239.52","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00118404"},{"key":"2024102021263076000_42.1.239.53","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(80)90003-2"},{"key":"2024102021263076000_42.1.239.54","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(93)90345-G"},{"key":"2024102021263076000_42.1.239.55","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1164\/ajrccm\/147.2.398","article-title":"A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids","volume":"147","author":"Nelson","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"2024102021263076000_42.1.239.56","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.4.2011040"},{"key":"2024102021263076000_42.1.239.57","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.6.1782"},{"key":"2024102021263076000_42.1.239.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.07.024"},{"key":"2024102021263076000_42.1.239.59","first-page":"CD002997","article-title":"Macrolides for chronic asthma","volume":"4","author":"Richeldi","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102021263076000_42.1.239.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.09.028"},{"key":"2024102021263076000_42.1.239.61","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldp028"},{"key":"2024102021263076000_42.1.239.62","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMoa1105482","article-title":"Changes in forced expiratory volume in 1 second over time in COPD","volume":"65","author":"Vestbo","year":"2011","journal-title":"N Engl J Med"},{"key":"2024102021263076000_42.1.239.63","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.040527"},{"key":"2024102021263076000_42.1.239.64","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.5.9709032"},{"key":"2024102021263076000_42.1.239.65","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.5.1449"},{"key":"2024102021263076000_42.1.239.66","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7245.1297"},{"key":"2024102021263076000_42.1.239.67","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063070"},{"key":"2024102021263076000_42.1.239.68","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805800"},{"key":"2024102021263076000_42.1.239.69","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200904-0492OC"},{"key":"2024102021263076000_42.1.239.70","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00178710"},{"key":"2024102021263076000_42.1.239.71","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-8-200704170-00152"},{"key":"2024102021263076000_42.1.239.72","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00208011"},{"key":"2024102021263076000_42.1.239.73","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1532-5415.2008.01725.x","article-title":"Inhibitory effects of macrolide antibiotics on exacerbations and hospitalization in chronic obstructive pulmonary disease in Japan: a retrospective multicenter analysis","volume":"56","author":"Yamaya","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"2024102021263076000_42.1.239.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2004.06.009"},{"key":"2024102021263076000_42.1.239.75","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.3.730"},{"key":"2024102021263076000_42.1.239.76","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pupt.2009.12.002","article-title":"Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy","volume":"3","author":"Blasi","year":"2010","journal-title":"Pulm Pharmacol Ther"},{"key":"2024102021263076000_42.1.239.77","first-page":"379","article-title":"Estudio prospective y comparativo (1994\u20131998) sobre la influencia corto profil\u00e1ctico con azitromicina en pacientes con EPOC evolucionada. [Prospective, comparative study (1994\u20131998) of the influence of short-term prophylactic treatment with azithromycin on patients with advanced COPD.]","volume":"13","author":"G\u00f3mez","year":"2000","journal-title":"Rev Esp Quimioter"},{"key":"2024102021263076000_42.1.239.78","doi-asserted-by":"publisher","DOI":"10.1159\/000321374"},{"key":"2024102021263076000_42.1.239.79","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200801-145OC"},{"key":"2024102021263076000_42.1.239.80","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104623"},{"key":"2024102021263076000_42.1.239.81","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0800353"},{"key":"2024102021263076000_42.1.239.82","unstructured":"Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013. Available from: www.goldcopd.org ."},{"key":"2024102021263076000_42.1.239.83","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-815602"},{"key":"2024102021263076000_42.1.239.84","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000295981.84633.bc"},{"key":"2024102021263076000_42.1.239.85","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200601-071OC"},{"key":"2024102021263076000_42.1.239.86","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00134307"},{"key":"2024102021263076000_42.1.239.87","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2009.12.003"},{"key":"2024102021263076000_42.1.239.88","first-page":"1","article-title":"Prevalence of selected chronic conditions: United States, 1990\u20131992","volume":"194","author":"Collins","year":"1997","journal-title":"Vital Health Stat"},{"key":"2024102021263076000_42.1.239.89","first-page":"73","article-title":"Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis","volume":"525","author":"Hashiba","year":"1996","journal-title":"Acta Otolaryngol Suppl"},{"key":"2024102021263076000_42.1.239.90","first-page":"33","article-title":"Clinical effect of low-dose, long-term roxithromycin chemotherapy in patients with chronic sinusitis","volume":"51","author":"Kimura","year":"1997","journal-title":"Acta Med Okayama"},{"key":"2024102021263076000_42.1.239.91","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.182.115"},{"key":"2024102021263076000_42.1.239.92","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2500\/105065800782102717","article-title":"Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage","volume":"14","author":"Yamada","year":"2000","journal-title":"Am J Rhinol"},{"key":"2024102021263076000_42.1.239.93","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)70100-8"},{"key":"2024102021263076000_42.1.239.94","doi-asserted-by":"publisher","DOI":"10.1378\/chest.125.2_suppl.41S"},{"key":"2024102021263076000_42.1.239.95","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2011.02693.x"},{"key":"2024102021263076000_42.1.239.96","first-page":"1","article-title":"European position paper on rhinosinusitis and nasal polyps 2012","volume":"23","author":"Fokkens","year":"2012","journal-title":"Rhinol Suppl"},{"key":"2024102021263076000_42.1.239.97","doi-asserted-by":"publisher","DOI":"10.3109\/01902148.2010.492895"},{"key":"2024102021263076000_42.1.239.98","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.biocel.2011.05.009","article-title":"Macrolides: new therapeutic perspectives in lung diseases","volume":"43","author":"Guillot","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"2024102021263076000_42.1.239.99","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.06.00013505"},{"key":"2024102021263076000_42.1.239.100","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.5.3611"},{"key":"2024102021263076000_42.1.239.101","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2739\/kurumemedj.43.207","article-title":"Neutrophil chemotactic activity in cryptogenic organizing pneumonia and the response to erythromycin","volume":"43","author":"Hotta","year":"1996","journal-title":"Kurume Med J"},{"key":"2024102021263076000_42.1.239.102","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050333"},{"key":"2024102021263076000_42.1.239.103","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-1908"},{"key":"2024102021263076000_42.1.239.104","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804877"},{"key":"2024102021263076000_42.1.239.105","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-2223"},{"key":"2024102021263076000_42.1.239.106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008072"},{"key":"2024102021263076000_42.1.239.107","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00029206"},{"key":"2024102021263076000_42.1.239.108","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20748"},{"key":"2024102021263076000_42.1.239.109","first-page":"CD005189","article-title":"Antibiotics for bronchiolitis in children","volume":"6","author":"Spurling","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2024102021263076000_42.1.239.110","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2009.01639.x"},{"key":"2024102021263076000_42.1.239.111","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(94)91030-8","article-title":"Ototoxicity with azithromycin","volume":"343","author":"Wallace","year":"1994","journal-title":"Lancet"},{"key":"2024102021263076000_42.1.239.112","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.302.1.320"},{"key":"2024102021263076000_42.1.239.113","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-007-7211-8"},{"key":"2024102021263076000_42.1.239.114","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003833"},{"key":"2024102021263076000_42.1.239.115","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00234-06"},{"key":"2024102021263076000_42.1.239.116","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkf512"},{"key":"2024102021263076000_42.1.239.117","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl014"},{"key":"2024102021263076000_42.1.239.118","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000247109.44249.ac"},{"key":"2024102021263076000_42.1.239.119","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-005-0375-1"},{"key":"2024102021263076000_42.1.239.120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2009.12.001"},{"key":"2024102021263076000_42.1.239.121","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01257-09"},{"key":"2024102021263076000_42.1.239.122","doi-asserted-by":"publisher","DOI":"10.1172\/JCI46095"},{"key":"2024102021263076000_42.1.239.123","unstructured":"US National Institutes of Health. ClinicalTrials.gov. http:\/\/clinicaltrials.gov\/ct2\/results?term=respiratory+diseases+AND+macrolides&pg=2 Date last accessed: May 7, 2013. Date last updated: May 3, 2013."},{"key":"2024102021263076000_42.1.239.124","doi-asserted-by":"publisher","DOI":"10.2174\/1381612043383322"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/09031936.00136712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:41:40Z","timestamp":1740379300000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/09031936.00136712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,22]]},"references-count":124,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,6,30]]},"published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1183\/09031936.00136712"],"URL":"https:\/\/doi.org\/10.1183\/09031936.00136712","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,22]]}}}